From EETimes: Researchers from Belgium have won $1.05 million funding from the Chan Zuckerberg Initiative (CZI), the philanthropic endeavor led by Facebook’s Mark Zuckerberg and his partner Priscilla Chan, to develop a new chip to study the mechanisms of Parkinson’s disease.
The funding, part of a $51.95 million program for CZI’s Neurodegeneration Challenge Network, aims to bring together experimental scientists from diverse biomedical research fields, as well as computational biologists and physicians to understand the underlying causes of neurodegenerative disorders. The Belgian team is led by professor Patrik Verstreken (VIB-KU Leuven), alongside clinical expert professor Wim Vandenberghe (UZ Leuven) and neuro-engineer Dr. Dries Braeken (imec).
Neurodegenerative disorders, including Alzheimer’s, Parkinson’s, Huntington’s disease, and ALS, are a class of diseases that affect millions of people worldwide. The causes of most of the diseases are only partly understood, and there are still no effective therapies to cure, prevent, or even treat most of these disorders.
View: Article @ Source Site
